Rankings
▼
Calendar
CAI Q2 2024 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
CAI
Caris Life Sciences, Inc.
$5B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$100M
Gross Profit
$38M
37.5% margin
Operating Income
$67M
67.0% margin
Net Income
-$66M
-66.2% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+24.0%
Cash Flow
Operating Cash Flow
-$63M
Free Cash Flow
-$66M
Stock-Based Comp.
$4M
← FY 2024
All Quarters
Q1 2025 →